S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:SKIN

Beauty Health (SKIN) Stock Forecast, Price & News

$8.30
-0.04 (-0.48%)
(As of 06/2/2023 ET)
Compare
Today's Range
$8.24
$8.69
50-Day Range
$8.04
$13.70
52-Week Range
$7.70
$16.02
Volume
1.68 million shs
Average Volume
1.93 million shs
Market Capitalization
$1.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.50

Beauty Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
134.9% Upside
$19.50 Price Target
Short Interest
Bearish
22.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.84mentions of Beauty Health in the last 14 days
Based on 16 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
1,650.00%
From $0.02 to $0.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Medical Sector

233rd out of 983 stocks

Surgical & Medical Instruments Industry

24th out of 98 stocks


SKIN stock logo

About Beauty Health (NASDAQ:SKIN) Stock

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Receive SKIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beauty Health and its competitors with MarketBeat's FREE daily newsletter.

SKIN Stock News Headlines

The gold catalyst we've waited for
Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Master Market Movements: Free Stock Analysis Report with Predictive Buy/Sell/Hold Insights!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Beauty Health (SKIN) Gets a Hold from J.P. Morgan
See More Headlines

SKIN Price History

SKIN Company Calendar

Last Earnings
11/08/2021
Today
6/02/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SKIN
Fax
N/A
Employees
1,034
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.50
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+134.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

Net Income
$44.38 million
Pretax Margin
-3.98%

Debt

Sales & Book Value

Annual Sales
$365.88 million
Cash Flow
$0.56 per share
Book Value
$1.11 per share

Miscellaneous

Free Float
87,152,000
Market Cap
$1.10 billion
Optionable
Optionable
Beta
1.14

Key Executives

  • Mr. Brenton L. Saunders J.D. (Age 52)
    Exec. Chairman
    Comp: $809.99k
  • Ms. Liyuan Woo (Age 50)
    Chief Financial Officer
    Comp: $910.5k
  • Mr. Daniel Copell Watson (Age 60)
    Exec. VP of Americas Sales
    Comp: $825.94k
  • Mr. Andrew Stanleick (Age 51)
    Pres, CEO & Director
  • Eduardo Rodriguez
    Sr. Director of M&A and Investor Relations
  • Mr. Paul Bokota
    VP & Gen. Counsel
  • Ms. Kellie Sears
    Chief HR Officer
  • Dr. Jwala Karnik M.D.
    Exec. VP of Strategy & Partnership
  • Mr. Benjamin C. Baum (Age 49)
    Chief Experience Officer
  • Mr. Mingo Ku
    Pres of North Asia













SKIN Stock - Frequently Asked Questions

Should I buy or sell Beauty Health stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beauty Health in the last twelve months. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SKIN shares.
View SKIN analyst ratings
or view top-rated stocks.

What is Beauty Health's stock price forecast for 2023?

8 brokers have issued 12 month target prices for Beauty Health's shares. Their SKIN share price forecasts range from $11.00 to $35.00. On average, they expect the company's stock price to reach $19.50 in the next year. This suggests a possible upside of 134.9% from the stock's current price.
View analysts price targets for SKIN
or view top-rated stocks among Wall Street analysts.

How have SKIN shares performed in 2023?

Beauty Health's stock was trading at $9.10 at the beginning of 2023. Since then, SKIN stock has decreased by 8.8% and is now trading at $8.30.
View the best growth stocks for 2023 here
.

When is Beauty Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our SKIN earnings forecast
.

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) released its quarterly earnings results on Monday, November, 8th. The company reported ($1.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $1.60. The business earned $68.15 million during the quarter, compared to analyst estimates of $59.57 million. Beauty Health had a negative trailing twelve-month return on equity of 3.57% and a negative net margin of 2.77%.

What guidance has Beauty Health issued on next quarter's earnings?

Beauty Health updated its FY 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $460.00 million-$480.00 million, compared to the consensus revenue estimate of $456.42 million.

What is Beauty Health's stock symbol?

Beauty Health trades on the NASDAQ under the ticker symbol "SKIN."

Who are Beauty Health's major shareholders?

Beauty Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (15.00%), BlackRock Inc. (4.53%), Wellington Management Group LLP (2.43%), American Century Companies Inc. (1.42%), State Street Corp (1.38%) and Geode Capital Management LLC (1.35%).

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Beauty Health's stock price today?

One share of SKIN stock can currently be purchased for approximately $8.30.

How much money does Beauty Health make?

Beauty Health (NASDAQ:SKIN) has a market capitalization of $1.10 billion and generates $365.88 million in revenue each year. The company earns $44.38 million in net income (profit) each year or ($0.22) on an earnings per share basis.

How many employees does Beauty Health have?

The company employs 1,034 workers across the globe.

How can I contact Beauty Health?

Beauty Health's mailing address is 1819 West Avenue Bay 2, Miami Beach FL, 33139. The official website for the company is hydrafacial.com. The company can be reached via phone at 800-603-4996 or via email at https://investors.beautyhealth.com.

This page (NASDAQ:SKIN) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -